Hennion & Walsh Asset Management, Inc.
Position in PCRX — Pacira BioSciences, Inc.
CIK 1861642
Parsippany, NJ
Position in PCRX
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$5,163,302
+$1,651,353 QoQ
Shares Held
203,520
+31.0% QoQ
Ownership
0.511%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#39
of 253 holders
Holding Since
Mar 2021
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Hennion & Walsh Asset Management, Inc. holds $46,273,526 across 11 Drug Manufacturers - Specialty & Generic names. PCRX ranks #3 (11.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INDV |
Indivior Pharmaceuticals, Inc.
|
360,245 | $14,780,852 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
327,801 | $11,105,897 | |
| 3 | PCRX |
Pacira BioSciences, Inc.
This page
|
203,520 | $5,163,302 | |
| 4 | SUPN |
Supernus Pharmaceuticals, Inc.
|
90,213 | $4,195,806 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
6,097 | $3,303,537 | |
| 6 | ALKS |
Alkermes plc.
|
47,317 | $2,479,174 | |
| 7 | VTRS |
Viatris Inc
|
104,642 | $1,661,714 | |
| 8 | BCRX |
Biocryst Pharmaceuticals Inc
|
112,893 | $1,128,930 |
All Filings in PCRX
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,163,302 | 203,520 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $3,511,949 | 155,396 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $3,574,157 | 138,105 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $1,311,564 | 50,895 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $1,238,545 | 51,822 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $1,347,267 | 54,216 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $1,062,293 | 56,385 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $718,622 | 47,749 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $1,014,224 | 35,450 | Shares | Sole | 2024-07-19 | |
| 2021-09-30 | $1,265,936 | 22,606 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,592,607 | 26,246 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,835,306 | 26,185 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||